Corvus Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 565,178 $3.72 $2,102,462
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 565,178 $3.72 $2,102,462
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 32,923 $3.34 $109,963
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 32,923 $3.34 $109,963
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 11,657 $3.4 $39,669
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 343 $3.52 $1,207
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 6,000 $3.67 $22,020
Purchase
LEA LEIV officer: Chief Financial Officer
Common Stock, $0.0001 par value 10,000 $3.38 $33,800
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 9,212 $3.37 $31,017
Purchase
LEA LEIV officer: Chief Financial Officer
Common Stock, $0.0001 par value 15,500 $3.56 $55,180
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 20,000 $3.29 $65,880
Purchase
LEA LEIV officer: Chief Financial Officer
Common Stock, $0.0001 par value 24,700 $4.15 $102,406
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 10,000 $4.39 $43,900
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 5,000 $5.99 $29,935
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 1,502 $5.95 $8,937
Purchase
NOVO HOLDINGS A/S 10 percent owner
COMMON STOCK 1,176,470 $8.5 $9,999,995
Purchase
ADAMS STREET PARTNERS LLC 10 percent owner
Common Stock, $0.0001 par value 588,235 $8.5 $4,999,998
Purchase
GOULD TERRY P director, 10 percent owner
Common Stock, $0.0001 par value 588,235 $8.5 $4,999,998
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 100,000 $8.5 $850,000
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 588,235 $8.5 $4,999,998
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 588,235 $8.5 $4,999,998
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 10,000 $10.79 $107,850
Purchase
NOVO HOLDINGS A/S 10 percent owner
COMMON STOCK 20,000 $10.95 $219,000
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 5,000 $10.14 $50,700
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 11,216 $9.82 $110,186
Purchase
MILLER RICHARD A MD director, officer: President an..
Common Stock, $0.0001 par value 8,784 $9.92 $87,137
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 900 $12.99 $11,691
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 900 $12.99 $11,691
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 100 $12.92 $1,292
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 100 $12.92 $1,292
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 26,083 $12.87 $335,688
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 26,083 $12.87 $335,688
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 12,300 $12.48 $153,504
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 12,300 $12.48 $153,504
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 5,000 $12.04 $60,200
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 5,000 $12.04 $60,200
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 5,000 $12.04 $60,200
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 5,000 $12.04 $60,200
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 10,000 $12.71 $127,100
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 10,000 $12.71 $127,100
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 20,000 $12.98 $259,600
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 20,000 $12.98 $259,600
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 30,000 $12.95 $388,500
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 30,000 $12.95 $388,500
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 4,716 $13.09 $61,732
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 4,716 $13.09 $61,732
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 2,600 $12.43 $32,318
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 2,600 $12.43 $32,318
Purchase
THOMPSON PETER A. director, 10 percent owner
Common Stock, $0.0001 par value 4,200 $11.55 $48,510
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
Common Stock, $0.0001 par value 4,200 $11.55 $48,510

Showing 50 to 100 of 108 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.